KDR and melanoma: Vemurafenib susceptible and resistant melanoma cells were analysed for the production of VEGF‐A and PlGF in culture supernatants and for the expression of VEGFR‐1 and VEGFR‐2 by ELISA and qRT‐PCR, respectively.